Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 23:11:389.
doi: 10.3389/fphys.2020.00389. eCollection 2020.

Molecular Mechanism of Hippo-YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration

Affiliations
Review

Molecular Mechanism of Hippo-YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration

Xiaoqing Chen et al. Front Physiol. .

Abstract

The Hippo-YAP1/TAZ pathway is a highly conserved central mechanism that controls organ size through the regulation of cell proliferation and other physical attributes of cells. The transcriptional factors Yes-associated protein 1 (YAP1) and PDZ-binding motif (TAZ) act as downstream effectors of the Hippo pathway, and their subcellular location and transcriptional activities are affected by multiple post-translational modifications (PTMs). Studies have conclusively demonstrated a pivotal role of the Hippo-YAP1/TAZ pathway in cardiac development, disease, and regeneration. Targeted therapeutics for the YAP1/TAZ could be an effective treatment option for cardiac regeneration and disease. This review article provides an overview of the Hippo-YAP1/TAZ pathway and the increasing impact of PTMs in fine-tuning YAP1/TAZ activation; in addition, we discuss the potential contributions of the Hippo-YAP1/TAZ pathway in cardiac development, disease, and regeneration.

Keywords: Hippo pathway; YAP1/TAZ; cardiac disease; heart development; post-translational modification; regeneration.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
The Hippo–YAP1/TAZ pathway in cardiac biology. Both YAP1 and TAZ are phosphorylated by core components, including Mst1/2, SAV1, Lats1/2, and MOB1, of the canonical Hippo pathway, and are subsequently degraded or stranded in the cytoplasm. Active YAP1/TAZ translocate to the nucleus, bind to transcriptional partners, and modulate downstream output in cardiac tissue. In addition, the Hippo-YAP1/TAZ pathway is regulated by several upstream pathways and cell-cell junctions. Line arrows indicate activation, whereas connector lines imply inhibition.

References

    1. Ambros V. (2004). The functions of animal microRNAs. Nature 431 350–355. 10.1038/nature02871 - DOI - PubMed
    1. Anorga S., Overstreet J. M., Falke L. L., Tang J., Goldschmeding R. G., Higgins P. J., et al. (2018). Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype. FASEB J. 32 2644–2657. 10.1096/fj.201700722R - DOI - PMC - PubMed
    1. Anzell A. R., Maizy R., Przyklenk K., Sanderson T. H. (2018). Mitochondrial quality control and disease: insights into ischemia-reperfusion injury. Mol. Neurobiol. 55 2547–2564. 10.1007/s12035-017-0503-9 - DOI - PMC - PubMed
    1. Artap S., Manderfield L. J., Smith C. L., Poleshko A., Aghajanian H., See K., et al. (2018). Endocardial Hippo signaling regulates myocardial growth and cardiogenesis. Dev. Biol. 440 22–30. 10.1016/j.ydbio.2018.04.026 - DOI - PMC - PubMed
    1. Badouel C., Zander M. A., Liscio N., Bagherie-Lachidan M., Sopko R., Coyaud E., et al. (2015). Fat1 interacts with Fat4 to regulate neural tube closure, neural progenitor proliferation and apical constriction during mouse brain development. Development 142 2781–2791. 10.1242/dev.123539 - DOI - PMC - PubMed